1. Home
  2. SNOA vs ISPC Comparison

SNOA vs ISPC Comparison

Compare SNOA & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • ISPC
  • Stock Information
  • Founded
  • SNOA 1999
  • ISPC 2009
  • Country
  • SNOA United States
  • ISPC United States
  • Employees
  • SNOA N/A
  • ISPC N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • ISPC Precision Instruments
  • Sector
  • SNOA Health Care
  • ISPC Health Care
  • Exchange
  • SNOA Nasdaq
  • ISPC Nasdaq
  • Market Cap
  • SNOA 6.9M
  • ISPC 6.9M
  • IPO Year
  • SNOA 2007
  • ISPC 2021
  • Fundamental
  • Price
  • SNOA $4.00
  • ISPC $0.80
  • Analyst Decision
  • SNOA
  • ISPC
  • Analyst Count
  • SNOA 0
  • ISPC 0
  • Target Price
  • SNOA N/A
  • ISPC N/A
  • AVG Volume (30 Days)
  • SNOA 76.8K
  • ISPC 572.0K
  • Earning Date
  • SNOA 11-07-2025
  • ISPC 11-14-2025
  • Dividend Yield
  • SNOA N/A
  • ISPC N/A
  • EPS Growth
  • SNOA N/A
  • ISPC N/A
  • EPS
  • SNOA N/A
  • ISPC N/A
  • Revenue
  • SNOA $14,912,000.00
  • ISPC $5,908,088.00
  • Revenue This Year
  • SNOA $23.00
  • ISPC $35.93
  • Revenue Next Year
  • SNOA $24.59
  • ISPC N/A
  • P/E Ratio
  • SNOA N/A
  • ISPC N/A
  • Revenue Growth
  • SNOA 17.43
  • ISPC N/A
  • 52 Week Low
  • SNOA $1.75
  • ISPC $0.64
  • 52 Week High
  • SNOA $6.92
  • ISPC $5.48
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 49.74
  • ISPC 41.78
  • Support Level
  • SNOA $3.57
  • ISPC $0.72
  • Resistance Level
  • SNOA $4.02
  • ISPC $0.86
  • Average True Range (ATR)
  • SNOA 0.23
  • ISPC 0.07
  • MACD
  • SNOA 0.00
  • ISPC 0.01
  • Stochastic Oscillator
  • SNOA 58.63
  • ISPC 37.06

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

Share on Social Networks: